Iterum Therapeutics PLC (ITRM) is up Wednesday morning, with the stock gaining 4.62% in pre-market trading to 1.36.
ITRM's short-term technical score of 5 indicates that the stock has traded less bullishly over the last month than 95% of stocks on the market. In the Biotechnology industry, which ranks 96 out of 146 industries, the stock ranks higher than 8% of stocks.
Iterum Therapeutics PLC has risen 44.44% over the past month, closing at $1.04 on December 23. During this period of time, the stock fell as low as $0.95 and as high as $1.45. ITRM has an average analyst recommendation of Sell. The company has an average price target of $1.75.
Iterum Therapeutics PLC has a Long-Term Technical rank of 64. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 36% of the market scoring higher. In the Biotechnology industry which is number 89 by this metric, ITRM ranks better than 62% of stocks.
Important Dates for Investors in ITRM:
-Iterum Therapeutics PLC is set to release earnings on 3/11/2021. During their last earnings release the company posted EPS of $-4.06. -We do not have a set dividend date for Iterum Therapeutics PLC at this time. Click Here to get the full Stock Score Report on Iterum Therapeutics PLC (ITRM) Stock.